1 July 2000 in Journal of Neuroscience
Transcripts for P2X2and P2X6subunits are present in rat CNS and frequently colocalize in the same brainstem nuclei. When rat P2X2(rP2X2) and rat P2X6(rP2X6) receptors were expressed individually inXenopusoocytes and studied under voltage-clamp conditions, only homomeric rP2X2receptors were fully functional and gave rise to large inward currents (2–3 μA) to extracellular ATP. Coexpression of rP2X2and rP2X6subunits inXenopusoocytes resulted in a heteromeric rP2X2/6receptor, which showed a significantly different phenotype from the wild-type rP2X2receptor. Differences included reduction in agonist potencies and, in some cases (e.g., Ap4A), significant loss of agonist activity. ATP-evoked inward currents were biphasic at the heteromeric rP2X2/6receptor, particularly when Zn2+ions were present or extracellular pH was lowered. The pH range was narrower for H+enhancement of ATP responses at the heteromeric rP2X2/6receptor. Also, H+ions inhibited ATP responses at low pH levels (<pH 6.3). The pH-dependent blocking activity of suramin was changed at this heteromeric receptor, although the potentiating effect of Zn2+on ATP responses was unchanged. Thus, the rP2X2/6receptor is a functionally modified P2X2-like receptor with a distinct pattern of pH modulation of ATP activation and suramin blockade. Although homomeric P2X6receptors function poorly, the P2X6subunit can contribute to functional heteromeric P2X channels and may influence the phenotype of native P2X receptors in those cells in which it is expressed.
1 December 2003 in British Journal of Pharmacology
1 April 1996 in British Journal of Pharmacology
A full pharmacological characterization was carried out on a recombinant ATP-gated ion channel (P2times2 purinoceptor) expressed in Xenopus oocytes. This slowly-desensitizing neuronal P2times2 purinoceptor, activated by ATP (EC50 = 4.6 ± 1 μm at pH 7.4; n 4), showed the agonist potency order: ATP ≥ 2- MeSATP = ATPγS ≥ ATPαS < < Bz-ATP. The receptor affinity for ATP was enhanced 5–10 fold by acidifying the bathing solution (to pH 6.5) but was diminished 4–5 fold in an alkaline solution (pH 8.0). The maximum activity of P2times2 purinoceptors and the activity order of a series of nucleotides were unaltered by changing extracellular pH. Interestingly, ATP sensitivity at a recombinant P2Y1, purinoceptor remained unaltered with changing extracellular pH. These results indicate that acidotic conditions in the synaptic cleft could strengthen purinergic transmission at neuronal P2times2 purinoceptors.
1 November 1999 in British Journal of Pharmacology
The antagonist activity of a series of diinosine polyphosphates (IpnI, where n=3, 4, 5) was assessed against ATP‐activated inward currents at rat P2X1–4 receptors expressed in Xenopus oocytes and studied under voltage‐clamp conditions. Diinosine polyphosphates were prepared by the enzymatic degradation of their corresponding diadenosine polyphosphates (e.g., Ap5A into Ip5I) using 5′‐adenylic deaminase, and purified using reverse‐phase chromatography. Against ATP‐responses at rP2X1 receptors, the potency order for antagonism was (pIC50): Ip5I (8.5)>Ip4I (6.3)>Ip3I (>4.5). Ip5I (10–100 nM) caused a concentration‐dependent rightwards displacement of the ATP concentration‐response curve without reducing the maximum ATP effect. However, the Schild plot was non‐linear which indicated Ip5I is not a competitive antagonist. Blockade by micromolar concentrations of Ip5I was not surmountable. Ip4I also behaved as a non‐surmountable antagonist. Against ATP‐responses at rP2X3 receptors, the potency order for antagonism was (pIC50): Ip4I (6.0)>Ip5I (5.6)>Ip3I (>4.5). Blockade by Ip4I (pA2, 6.75) and Ip5I (pA2, 6.27) was surmountable at micromolar concentrations. Diinosine polyphosphates failed to inhibit ATP‐responses at rP2X2 receptors, whereas agonist responses at rP2X4 were reversibly potentiated by Ip4I and Ip5I. None of the parent diadenosine polyphosphates behave as antagonists at rP2X1–4 receptors. Thus, Ip5I acted as a potent and relatively‐selective antagonist at the rP2X1 receptor. This dinucleotide pentaphosphate represents a high‐affinity antagonist for the P2X1 receptor, at which it acts in a competitive manner at low (100 nM) concentrations but has more complex actions at higher (>100 nM) concentrations. British Journal of Pharmacology (1999) 128, 981–988; doi:10.1038/sj.bjp.0702876
1 February 2002 in The Journal of Pharmacology and Experimental Therapeutics
ATAndrea Townsend-Nicholson
Andrea Townsend-Nicholson
Rat P2X1 and P2X2 subunits were coexpressed in defolliculated Xenopus oocytes and the resultant P2X receptors studied under voltage-clamp conditions. Extracellular ATP elicited biphasic inward currents, involving an initial rapidly inactivating (P2X1-like) component and a later slowly inactivating (P2X2-like) component. The maximum amplitude of P2X1-like ATP responses was increased in some cells by lowering extracellular pH (from 7.5 to 6.5), whereas P2X2-like responses and those of homomeric rP2X1 and rP2X2 receptors were not changed by this treatment. Concentration-response (C/R) curves for ATP for pH-enhanced P2X1-like responses were biphasic, and clearly distinct from monophasic ATP C/R curves for homomeric rP2X1and rP2X2 receptors. Under acidic (pH 5.5 and 6.5) and alkaline (pH 8.5) conditions, ATP C/R curves for P2X1-like responses showed increases in agonist potency and efficacy, compared with data at pH 7.5, but the same was not true of homomeric rP2X1 and rP2X2 receptors. ATP C/R curves for P2X2-like responses overlay C/R curves for homomeric rP2X2 receptors, and determinations of agonist potency and efficacy were identical for P2X2-like and P2X2responses at all pH levels tested. Our results show that P2X1-like responses possessed the kinetics of homomeric P2X1 receptors but an acid sensitivity different from homomeric P2X1 and P2X2 receptors. In contrast, the P2X2-like responses exactly matched the profile expected of homomeric P2X2 receptors. Thus, coexpression of P2X1 and P2X2 subunits yielded a mixed population of homomeric and heteromeric P2X receptors, with a subpopulation of novel pH-sensitive P2X receptors showing identifiably unique properties that indicated the formation of heteromeric P2X1/2 ion channels.
1 September 1999 in British Journal of Pharmacology
The modulatory activity of extracellular H+ and Zn2+ was examined on ATP‐responses at rat P2X1 (rP2X1) and rat P2X3 (rP2X3) receptors expressed in Xenopus oocytes and studied under voltage‐clamp conditions. Superfused ATP (0.03–30 μM, at pH 7.5) evoked inward currents at rP2X1 receptors (EC50 value, 300±7 nM). ATP potency was reduced 2 fold at pH 6.5, and 6 fold at pH 5.5, without altering the maximum ATP effect. Alkaline conditions (pH 8.0) did not alter ATP activity. Superfused ATP (0.01–300 μM, at pH 7.5) evoked inward currents at rP2X3 receptors (EC50 value, 1.8±0.3 μM). ATP activity was affected only at pH 5.5, reducing agonist potency 15 fold without altering the maximum ATP effect. Extracellular Zn2+ inhibited ATP‐responses at rP2X1 receptors in a time‐dependent manner, a 20 min pre‐incubation being optimal (IC50 value, 1.0±0.2 μM). However, the Zn2+ effect was pH‐independent, suggesting Zn2+‐ and H+‐inhibition of ATP‐responses occur through independent processes. Extracellular Zn2+ weakly potentiated ATP‐responses at rP2X3 receptors (EC50 value, 11±1 μM). The Zn2+ effect was dependent on pre‐incubation time and, with 20 min pre‐incubation periods, Zn2+ potentiated then inhibited ATP‐responses in a concentration‐dependent, but pH‐independent, manner. In summary, ATP activity at rP2X1 receptors was decreased by both extracellular H+ and Zn2+ and their effects were additive. ATP activity at rP2X3 receptors was less sensitive to H+‐inhibition and, in contrast, was potentiated by Zn2+ in a pH‐independent manner. These differential effects may help distinguish P2X1 and P2X3 receptors in whole tissues. British Journal of Pharmacology (1999) 128, 486–492; doi:10.1038/sj.bjp.0702802